Quanterix (QTRX) Research & Development (2017 - 2026)
Quanterix (QTRX) posted Research & Development of $7.3 million for Q1 2026, down 16.75% on a QoQ basis from $8.8 million in Q4 2025, and down 27.03% year-over-year from $10.0 million in Q1 2025.
Quanterix (QTRX) Research & Development (2017 - 2026) Analysis & Trends
Quanterix's Research & Development history runs 10 years deep, the most recent figure standing at $7.3 million for Q1 2026.
- Quarterly Research & Development fell 27.03% year-over-year to $7.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $33.2 million (down 3.39% YoY) and the FY2025 annual result came in at $35.9 million, up 15.57% from the prior year.
- Research & Development was $7.3 million for Q1 2026 at Quanterix, down from $8.8 million in the prior quarter.
- Across five years, Research & Development topped out at $10.0 million in Q1 2025 and bottomed at $5.0 million in Q1 2023.
- A 5-year average of $7.5 million and a median of $7.3 million in 2026 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2022 — Research & Development decreased 28.21% — and 2025, when it jumped 48.86%.
- Quanterix's Research & Development stood at $5.8 million in 2022, then rose by 23.4% to $7.2 million in 2023, then grew by 11.89% to $8.1 million in 2024, then increased by 9.04% to $8.8 million in 2025, then declined by 16.75% to $7.3 million in 2026.
- Business Quant data shows QTRX's Research & Development at $7.3 million in Q1 2026, $8.8 million in Q4 2025, and $8.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 145.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -461.27 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 345.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Quanterix | 184.16 Mn | 84.89 Mn | 15.57 Mn | 7.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.32 Mn |
| Dec 31, 2025 | 8.80 Mn |
| Sep 30, 2025 | 8.01 Mn |
| Jun 30, 2025 | 9.08 Mn |
| Mar 31, 2025 | 10.04 Mn |
| Dec 31, 2024 | 8.07 Mn |
| Sep 30, 2024 | 8.10 Mn |
| Jun 30, 2024 | 8.17 Mn |
| Mar 31, 2024 | 6.74 Mn |
| Dec 31, 2023 | 7.21 Mn |
| Sep 30, 2023 | 7.74 Mn |
| Jun 30, 2023 | 6.13 Mn |
| Mar 31, 2023 | 4.99 Mn |
| Dec 31, 2022 | 5.84 Mn |
| Sep 30, 2022 | 6.83 Mn |
| Jun 30, 2022 | 7.26 Mn |
| Mar 31, 2022 | 6.88 Mn |
| Dec 31, 2021 | 8.14 Mn |
| Sep 30, 2021 | 6.81 Mn |
| Jun 30, 2021 | 6.75 Mn |